The All of Us Research Program: data quality, utility, and diversity

Author:

Ramirez Andrea H.,Sulieman Lina,Schlueter David J.,Halvorson Alese,Qian Jun,Ratsimbazafy Francis,Loperena RoxanaORCID,Mayo Kelsey,Basford Melissa,Deflaux Nicole,Muthuraman Karthik N.,Natarajan Karthik,Kho Abel,Xu Hua,Wilkins Consuelo,Anton-Culver Hoda,Boerwinkle Eric,Cicek Mine,Clark Cheryl R.,Cohn Elizabeth,Ohno-Machado Lucila,Schully Sheri,Ahmedani Brian K.,Argos Maria,Cronin Robert M.ORCID,O’Donnell Christopher,Fouad Mona,Goldstein David B.,Greenland Philip,Hebbring Scott J.,Karlson Elizabeth W.,Khatri Parinda,Korf BruceORCID,Smoller Jordan W.,Sodeke Stephen,Wilbanks John,Hentges Justin,Lunt Christopher,Devaney Stephanie A.,Gebo Kelly,C Denny Joshua,Carroll Robert J.,Glazer David,Harris Paul A.,Hripcsak George,Philippakis Anthony,Roden Dan M.

Abstract

AbstractImportanceThe All of Us Research Program hypothesizes that accruing one million or more diverse participants engaged in a longitudinal research cohort will advance precision medicine and ultimately improve human health. Launched nationally in 2018, to date All of Us has recruited more than 345,000 participants. All of Us plans to open beta access to researchers in May 2020.ObjectiveTo demonstrate the quality, utility, and diversity of the All of Us Research Program’s initial data release and beta launch of the cloud-based analysis platform, the cloud-based Researcher Workbench.EvidenceWe analyzed the initial All of Us data release, comprising surveys, physical measurements (PM), and electronic health record (EHR) data, to characterize All of Us participants including self-reported descriptors of diversity. Data depth, density, and quality were evaluated using medication sequencing analyses for depression and type 2 diabetes. Replication of known oncologic associations with smoking exposure ascertained by EHR and survey data and calculation of population-based atherosclerotic cardiovascular disease risk scores demonstrated the utility of data and platform capability.FindingsThe beta launch of the All of Us Researcher Workbench contains data on 224,143 participants. Seventy-seven percent of this cohort were identified as Underrepresented in Biomedical Research (UBR) including over forty-eight percent self-reporting non-White race. Medication usage patterns in common diseases depression and type 2 diabetes replicated prior findings previously reported in the literature and showed differences based on race. Oncologic associations with smoking were replicated and effect sizes compared for EHR and survey exposures finding general agreement. A cardiovascular disease score was calculated utilizing multiple data elements curated across sources. The cloud-based architecture built in the Researcher Workbench provided secure access and powerful computational resources at a low cost. All analyses have been made available for replication and reuse by registered researchers.Conclusions and RelevanceThe All of Us Research Program’s initial release of cohort data contains longitudinal and multidimensional data on diverse participants that replicate known associations. This dataset and the cloud-based Researcher Workbench advance the mission of All of Us to make data widely and securely available to researchers to improve human health and advance precision medicine.

Publisher

Cold Spring Harbor Laboratory

Reference41 articles.

1. The “All of Us” Research Program

2. Reference GH . What is precision medicine? Genetics Home Reference. Accessed May 4, 2020. https://ghr.nlm.nih.gov/primer/precisionmedicine/definition

3. The Precision Medicine Initiative Cohort Program – Building a Research Foundation for 21st Century Medicine.:108.

4. All of Us

5. Workbench – All of Us Research Hub. Accessed April 23, 2020. https://www.researchallofus.org/workbench/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3